Fosun Pharma will invest $73.5 million over nine years in an innovative technology incubator. The incubator will search worldwide for innovative projects, which Fosun said will help meet its stategic innovative and global goals. Professor Tian Xu, deputy head of Genetics at Yale University and Chief Science Advisor to Fosun, will serve as the chairman of the incubator’s academic committee. The Fosun incubator will seek innovative technologies in pharmaceuticals, regenerative medicine and artificial intelligence.
